Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

Alexza Pharmaceuticals | Headlines

  • Vol:
  • Last Trade:
Search found 21 documents NextNext
1: Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
PR NEWSWIRE, November 19, 2009 04:15 PM

2: Alexza Reports 2009 Third Quarter Financial Results and Updates AZ-004 (Staccato(R) Loxapine) NDA Status
PR NEWSWIRE, November 9, 2009 04:05 PM

3: Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
PR NEWSWIRE, November 2, 2009 04:30 PM

4: Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
PR NEWSWIRE, October 2, 2009 09:30 AM

5: Alexza to Raise $19.7 Million in Private Placement
PR NEWSWIRE, September 30, 2009 09:37 AM

6: Alexza Appoints Andrew L. Busser to Board of Directors
PR NEWSWIRE, September 25, 2009 10:05 AM

7: Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
PR NEWSWIRE, September 14, 2009 07:30 AM

8: Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
PR NEWSWIRE, September 8, 2009 06:00 PM

9: Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro
PR NEWSWIRE, August 26, 2009 04:10 PM

10: Alexza Reports 2009 Second Quarter Financial Results and Updates Clinical Pipeline Status
PR NEWSWIRE, August 5, 2009 04:10 PM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top